Table 3.
Sample | CIP (µg/mL)a | Sus. | TOB (µg/mL)a | Sus. |
---|---|---|---|---|
1b | 4.00 | R | 8.00 | R |
2b | 0.19 | S | 2.00 | S |
3b | 0.13 | S | 2.00 | S |
4b | 0.094 | S | 1.50 | S |
5b | 0.25 | S | 0.25 | S |
6b | 12.00 | R | ≤256 | R |
7b | 0.19 | S | 3.00 | S |
8b | 0.38 | S | 4.00 | S |
9b | 0.094 | S | 1.00 | S |
10b | 0.094 | S | 1.00 | S |
11c | 2.00 | R | 32.00 | R |
12d | 0.094 | S | 1.50 | S |
13d | 0.094 | S | 1.00 | S |
14e | 0.094 | S | 1.50 | S |
15f | 0.094 | S | 1.00 | S |
16d | ≤32 | R | ≤256 | R |
Drugs: CIP, ciprofloxacin (S≤1; I 2; R≥4); TOB, tobramycin (S≤4; I 8; R≥16). Sus: Susceptibilities; S: susceptible; R: resistant.
Strain isolated from dog.
Strain isolated from cat.
Strain isolated from horse.
Strain isolated from penguin.
Strain isolated from black bear.